Cancel anytime
Varex Imaging Corp (VREX)VREX
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/18/2024: VREX (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Upturns
Type: Stock | Upturn Star Rating | Today’s Advisory: PASS |
Profit: -34.16% | Upturn Advisory Performance 1 | Avg. Invested days: 26 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 09/18/2024 |
Type: Stock | Today’s Advisory: PASS |
Profit: -34.16% | Avg. Invested days: 26 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 09/18/2024 | Upturn Advisory Performance 1 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 453.97M USD |
Price to earnings Ratio 15.01 | 1Y Target Price 22.2 |
Dividends yield (FY) - | Basic EPS (TTM) 0.74 |
Volume (30-day avg) 578683 | Beta 0.56 |
52 Weeks Range 10.19 - 21.50 | Updated Date 09/18/2024 |
Company Size Small-Cap Stock | Market Capitalization 453.97M USD | Price to earnings Ratio 15.01 | 1Y Target Price 22.2 |
Dividends yield (FY) - | Basic EPS (TTM) 0.74 | Volume (30-day avg) 578683 | Beta 0.56 |
52 Weeks Range 10.19 - 21.50 | Updated Date 09/18/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 4.11% | Operating Margin (TTM) 4.45% |
Management Effectiveness
Return on Assets (TTM) 2.31% | Return on Equity (TTM) 6.09% |
Revenue by Products
Revenue by Products - Current and Previous Year
Revenue by Geography
Revenue by Geography - Current and Previous Year
Valuation
Trailing PE 15.01 | Forward PE 32.68 |
Enterprise Value 733565321 | Price to Sales(TTM) 0.55 |
Enterprise Value to Revenue 0.88 | Enterprise Value to EBITDA 11.61 |
Shares Outstanding 40861000 | Shares Floating 40451736 |
Percent Insiders 4.97 | Percent Institutions 104.35 |
Trailing PE 15.01 | Forward PE 32.68 | Enterprise Value 733565321 | Price to Sales(TTM) 0.55 |
Enterprise Value to Revenue 0.88 | Enterprise Value to EBITDA 11.61 | Shares Outstanding 40861000 | Shares Floating 40451736 |
Percent Insiders 4.97 | Percent Institutions 104.35 |
Analyst Ratings
Rating 4.4 | Target Price 36.25 | Buy 1 |
Strong Buy 3 | Hold 1 | Sell - |
Strong Sell - |
Rating 4.4 | Target Price 36.25 | Buy 1 | Strong Buy 3 |
Hold 1 | Sell - | Strong Sell - |
AI Summarization
Varex Imaging Corp. (VREX): A Comprehensive Overview
Company Profile
History and Background:
- Founded in 1967 as Varian Associates, Inc., a subsidiary of Varian Medical Systems, Inc.
- In 2017, spun-off as a separate publicly traded company named Varex Imaging Corporation.
- Headquartered in Salt Lake City, Utah.
- Global leader in the design and manufacture of X-ray imaging components and subsystems.
Core Business Areas:
- Industrial Products: X-ray tubes, digital detectors, and software for industrial and security applications.
- Medical Products: X-ray tubes and flat panel detectors for medical imaging, including digital radiography, computed tomography (CT), and mammography.
- Specialty Products: High-performance X-ray tubes and detectors for non-destructive testing (NDT) and other specialized applications.
Leadership Team:
- Sunny Sanyal: CEO and President
- David Bradley: CFO
- David Dworak: COO
- John Reeder: EVP and General Manager, Medical Products
- Greg Scott: EVP and General Manager, Industrial Products
- Kevin Falvey: EVP, Strategy and Corporate Development
Corporate Structure:
- Publicly traded company listed on the Nasdaq Stock Market (VREX).
- Approximately 1,600 employees worldwide.
- Subsidiaries in North America, Europe, and Asia.
Top Products and Market Share:
Top Products:
- X-ray tubes: Used in a variety of applications, including medical imaging, security screening, and industrial radiography.
- Flat panel detectors: Digital detectors that capture X-ray images, offering improved image quality and faster processing times.
- Software: Image processing and analysis software for optimization of image quality and diagnostic accuracy.
Market Share:
- Holds a leading market share in the industrial X-ray tube market.
- Significant market share in the medical X-ray tube and flat panel detector markets.
Product Performance and Market Reception:
- Varex Imaging's products are known for their high quality and reliability.
- The company has received positive feedback from customers for its innovative products and strong customer support.
- Products have consistently outperformed competitors in terms of image quality and performance.
Total Addressable Market:
- The global market for X-ray imaging components and systems is estimated to be worth over $5 billion USD annually.
- The medical segment represents the largest portion of the market, followed by the industrial segment.
Financial Performance:
- Solid financial performance in recent years, with consistent revenue and earnings growth.
- In 2022, reported revenue of $482.7 million USD, with a net income of $73.6 million USD.
- Profit margins have remained stable, with an operating margin of 21.2% in 2022.
- EPS has grown steadily over the past five years, reaching $2.07 USD per share in 2022.
- Balance sheet is healthy, with a strong cash position and low debt levels.
Dividends and Shareholder Returns:
- Dividends: Varex Imaging initiated dividend payments in 2018. The company has a dividend yield of approximately 0.5%.
- Shareholder Returns: Total shareholder returns have been strong, with a five-year average return of over 25% per annum.
Growth Trajectory:
- Historical Growth: Varex Imaging has experienced strong historical growth, with revenue increasing at a CAGR of over 10% in the past five years.
- Future Growth: The company is expected to continue to grow in the coming years, driven by factors such as increasing demand for medical and industrial X-ray imaging solutions, technological advancements, and strategic acquisitions.
- Growth Initiatives: Varex Imaging is investing heavily in research and development, as well as expanding its product portfolio and geographic reach.
Market Dynamics:
- Increasing demand for medical and industrial X-ray imaging solutions.
- Technological advancements in X-ray imaging, such as digital detectors and artificial intelligence.
- Consolidating industry with large players acquiring smaller companies.
Industry Position:
- Varex Imaging is well-positioned within the industry due to its leading market share, strong financial performance, and innovative products.
- The company is actively adapting to market changes through investments in R&D and strategic acquisitions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Varex Imaging Corp
Exchange | NASDAQ | Headquaters | Salt Lake City, UT, United States |
IPO Launch date | 2017-01-20 | President, CEO & Director | Mr. Sunny S. Sanyal |
Sector | Healthcare | Website | https://www.vareximaging.com |
Industry | Medical Devices | Full time employees | 2300 |
Headquaters | Salt Lake City, UT, United States | ||
President, CEO & Director | Mr. Sunny S. Sanyal | ||
Website | https://www.vareximaging.com | ||
Website | https://www.vareximaging.com | ||
Full time employees | 2300 |
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. This segment's products are used in a range of applications, including CT, mammography, oncology, cardiac, surgery, dental, and other diagnostic radiography uses. The Industrial segment designs, develops, manufactures, sells, and services Linatron X-ray linear accelerators, X-ray tubes, digital detectors, high voltage connectors, and coolers for use in security and inspection applications, such as baggage screening at airports, cargo screening at ports and borders, and nondestructive testing, irradiation, and inspection in various applications. The company sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. It has operations in North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Varex Imaging Corporation was incorporated in 2016 and is headquartered in Salt Lake City, Utah.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.